Cancer Stem Cells Market Size, Growth, Global Trends, Forecast 2034

Cancer Stem Cells Industry Perspective:

The global cancer stem cells market size was worth around USD 3.10 billion in 2024 and is predicted to grow to around USD 9.46 billion by 2034, with a compound annual growth rate (CAGR) of roughly 11.80% between 2025 and 2034.

Request Free Sample

Key Insights:

• As per the analysis shared by our research analyst, the global cancer stem cells market is estimated to grow annually at a CAGR of around 11.80% over the forecast period (2025-2034)
• In terms of revenue, the global cancer stem cells market size was valued at around USD 3.10 billion in 2024 and is projected to reach USD 9.46 billion by 2034.
• The cancer stem cells market is projected to grow at a significant rate due to the rising prevalence of cancer.
• Based on the mode of action, the inhibition of the self-renewal pathways segment is growing at a high rate. It will continue to dominate the global market as per industry projections.
• Based on the cancer type, the breast cancer segment is anticipated to command the largest market share.
• Based on region, North America is projected to dominate the global market during the forecast period.

Cancer Stem Cells Market: Overview

Cancer stem cells (CSCs) are a small subset of cancer cells that display properties of stem cells, such as continuous proliferation and self-renewal. CSCs are responsible for metastasis in cancer patients, tumorigenesis, and maintaining tumor heterogeneity. In addition to this, research confirms that cancer stem cells are resistant to conventional cancer therapies, which can lead to the failure of treatment and tumor recurrence. Cancer researchers are focusing on understanding the role of CSCs in cancer since it can help them develop more effective treatments that can prevent cancer relapse and improve therapy outcomes. The unique properties of cancer stem cells include CD44, ALDH1, and CD133, depending on the type of cancer. Furthermore, since they generally stay in the system in a non-aggressive form, cancer stem cells remain undetected and lead to excessive multiplication of cancer cells.

During the forecast period, demand for research on cancer stem cells is expected to continue growing due to the rising prevalence of cancer. Additionally, growing demand for precision and targeted cancer therapies will fuel the market expansion rate. Over the projection duration, rising investments in stem cell research will instill greater growth opportunities for the industry players. However, the high cost of investment in CSCs research will impact market revenue in the long run.

Cancer Stem Cells Market: Market Dynamics

Growth Drivers

Will the rising prevalence of cancer promote the cancer stem cells market expansion in the future?

The global cancer stem cells market is expected to be driven by the rising prevalence of the disease worldwide. According to official reports, cancer is a major cause of global health concerns as the number of cancer patients worldwide continues to grow rapidly. In addition to this, current methods of cancer treatment are ineffective in treating cancer when it has reached advanced stages.

Furthermore, a lack of sufficient therapies for rare cancers further increases the burden on the healthcare industry. As per the World Health Organization (WHO), nearly 1 in 6 deaths reported in 2020 were due to cancer. A number of genetic, environmental, and lifestyle factors can lead to the onset of a serious medical condition.

For instance, frequent exposure to toxic gases and contaminants can lead to certain types of cancer. On the other hand, regular consumption of alcohol, tobacco, and ultra-processed food is also deemed a leading cause of cancer among the younger population. Cancer care disparity is more evident in low-income or developing countries that have a vulnerable healthcare infrastructure. Research on cancer stem cells can help drug developers produce more effective drugs and treatments against cancer.

Rising demand for precision medicine opens new avenues for growth in the industry

Precision or targeted medical therapies are gaining growth momentum in the healthcare and research segments. Precision medical treatments are designed according to the specific health-related requirements of patients. Targeted treatment leverages molecular and genetic profiling to design medical plants that are expected to deliver optimal results as compared to standard counterparts. Medical professionals worldwide are increasingly investing in precision care for patients with chronic and serious conditions, driving higher revenue in the global cancer stem cells market.

Restraints

Does the shigh cost of investment negatively affect the cancer stem cells market revenue in the long run?

The global cancer stem cells market is expected to be restricted due to the high cost of investment associated with the research & development conducted with CSCs. Isolation of cancer stem cells is a complicated process because of the rarity of the cells. According to official estimates, cancer stem cells make up less than 1% of overall tumor cells. In addition to this, further processes can be carried out using only next-generation tools and technologies such as multi-omics profiling, live-cell imaging, and lineage tracing, adding to the overall cost of investment. These factors are likely to impact market revenue in the long run.

Opportunities

Will amplifying investments in stem cell research initiatives and government support create growth opportunities for the cancer stem cells industry?

The global cancer stem cells market is projected to generate growth opportunities due to the rising investments in stem cell research across the globe. In January 2022, Novo Nordisk Foundation announced that it would invest up to USD 343 million over the next 10 years in developing an international research center focusing primarily on stem cell medicine. On the other hand, in April 2023, the board of the California Institute for Regenerative Medicine (CIRM) announced an approval of USD 89 million for Translation and Clinical programs by the institute. These investments will be directed toward stem cell & gene therapy studies.

Additionally, growing government support for cancer and stem cell-based research programs will further help the industry thrive during the projection period. In March 2025, the Government of Canada announced it would invest CAD49.9 million in STEMCELL Technologies Canada Inc. The company is building state-of-the-art biomanufacturing facilities for producing critical raw materials required for the development of novel vaccines, diagnostic technologies, and therapeutics. Cancer stem cell research is a segment of the broader stem cell studies, and a better understanding of the latter can have serious positive implications for the expansion of CSC-based projects.

Challenges

Technical complexities in diagnosing and treating CSCs challenge industry growth

The global cancer stem cells industry is projected to be challenged by the presence of several technical complexities in diagnosing and treating cancer-causing stem cells. For instance, the industry lacks access to standard CSC markers since cancer stem cells tend to vary depending on cancer types and sometimes within the same tumor.

Moreover, heterogeneity showcased by CSCs makes them eliminate them completely, leading to relapse and resistance to treatments. Other factors, such as a limited number of clinical trials and regulatory constraints, may impact market expansion during the projection period.

Cancer Stem Cells Market: Report Scope

Cancer Stem Cells Market: Segmentation

The global cancer stem cells market is segmented based on mode of action, cancer type, and region.

Based on the mode of action, the global market segments are immune modulation, cancer stem cells surface marker targeting, inhibition of self-renewal pathways, apoptosis induction, differentiation therapy, drug efflux inhibition, and epigenetic modulation. In 2024, around 50% of the total revenue was listed in the inhibition of self-renewal pathways segment due to their higher efficiency in targeting and eliminating key characteristics of CSCs. During the projection period, similar trends can be expected as the mode of action continues to draw global attention.

Based on the cancer type, the global market divisions are blood cancer, colorectal cancer, breast cancer, liver cancer, pancreatic cancer, bladder cancer, lung cancer, and others. In 2024, more than 25% of the final market share was dominated by the breast cancer segment due to the growing prevalence of the disease among women. Additionally, blood cancer emerged as the second-highest segment, followed by lung cancer. Increasing demand for personalized cancer care and therapies will fuel increased market revenue during the projection period.

Cancer Stem Cells Market: Regional Analysis

What factors help North America to continue its lead in the cancer stem cells market?

The global cancer stem cells market is projected to be led by North America during the forecast period. The region enjoys the presence of a robust infrastructure supporting advanced cancer research, including studies on CSCs. The US and Canada are the leading regional market revenue generators due to their highly advanced medical care system, as well as a thriving biotechnological research sector.

In recent times, the US has emerged as one of the world’s most prominent and influential nations in terms of stem cell research, led by growing government and private investments.

According to the latest trends, the Asia-Pacific region is poised to emerge as the fastest-growing market, driven by the increasing prevalence of cancer within the regional healthcare industry. The presence of several emerging companies focusing on stem cell research and increased government-backed projects will aid regional expansion.

Moreover, a rising number of strategic partnerships between government healthcare agencies and private companies in the drug development and healthcare industries will facilitate greater expansion of the Asia-Pacific market during the forecast period. Additionally, growing international collaborations between Asian countries to promote advancements in cancer research will be helpful to the regional industry.

Cancer Stem Cells Market: Competitive Analysis

The global cancer stem cells market is led by players like:

• PromoCell GmbH
• Thermo Fisher Scientific
• Bionomics
• FUJIFILM Irvine Scientific
• Lineage Cell Therapeutics
• The Menarini Group
• AbbVie
• OncoMed Pharmaceuticals
• Sino Biological
• Merck KGaA
• Genentech (Roche)
• Lonza
• STEMCELL Technologies
• Miltenyi Biotec
• MacroGenics

The global cancer stem cells market is segmented as follows:

By Mode of Action

• Immune Modulation
• Cancer Stem Cells Surface Marker Targeting
• Inhibition of Self-Renewal Pathways
• Apoptosis Induction
• Differentiation Therapy
• Drug Efflux Inhibition
• Epigenetic Modulation

By Cancer Type

• Blood Cancer
• Colorectal Cancer
• Breast Cancer
• Liver Cancer
• Pancreatic Cancer
• Bladder Cancer
• Lung Cancer
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa